readthroughSign in
CompanyNasdaqMinneapolis, MN

Celcuity Inc

Celcuity develops REVTORPYK (gedatolisib), a pan-PI3K and mTORC1/2 inhibitor for solid tumors.

SCHEDULE 13G/ANov 16Latest SEC filing
Form DSep 23$130M sold